描述
Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.
Figure 22
Source Paper
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?Cite This Figure
![Figure 22: Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.]() > Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)
<figure> <img src="" alt="Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms." /> <figcaption>Figure 22. Renal function and kidney disease progression data for EPA versus DHA reveal potential differences in nephroprotective mechanisms.<br> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption> </figure>